4.7 Article

FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Peptide-like and small-molecule inhibitors against Covid-19

Suyash Pant et al.

Summary: The study identified potential protease inhibitors against SARS-CoV-2 using computational approaches, screening compounds from various databases and conducting docking and molecular dynamics simulations to find promising drugs.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Review Biochemistry & Molecular Biology

A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin

Anwarul Hasan et al.

Summary: This review discusses the interactions between the novel coronavirus SARS-CoV-2 and human cells, highlighting the role of important receptors like ACE-2 and furin in the virus invasion. It explores the potential inhibitory effects of compounds on the virus, as well as future prospects for drug development.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biochemistry & Molecular Biology

Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase

Rameez Jabeer Khan et al.

Summary: The study focused on identifying promising inhibitors from pre-existing antiviral drugs targeting two druggable proteins, 3CLpro and 2'-O-MTase, through screening and MD simulations to suggest potential therapeutic drugs against SARS-CoV-2.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biochemistry & Molecular Biology

Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations

I. Aanouz et al.

Summary: The new coronavirus, known as SARS-CoV-2, first appeared in Wuhan, China. Research is being done on natural herbal remedies, with three molecules showing potential as inhibitors against the coronavirus.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biochemistry & Molecular Biology

Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment

Subramanian Boopathi et al.

Summary: The world has faced several infectious disease outbreaks in the past two decades, with the novel coronavirus 2019 having a significant global impact. With millions infected and thousands dead, only a few Asian countries have managed to control the disease, but a second wave of infections is expected. Predicting inhibitors and targets for COVID-19 is urgent, with computer-aided drug design playing a crucial role in this process.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biochemistry & Molecular Biology

Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2viaintegrated computational approach

Salman Ali Khan et al.

Summary: In response to the outbreak of SARS-CoV-2, researchers are investigating the development of antiviral drugs targeting the Chymotrypsin-like protease to combat the infection. Through computational drug design methods, potential inhibitors have been identified from FDA-approved antiviral drugs and natural compounds, with further evaluation of their binding affinity and stability through MD simulation and binding free energy calculations. The results suggest that these compounds have the potential to inhibit the function of Coronavirus' Chymotrypsin-like protease, contributing to the search for new inhibitors against the vital pathway of the virus for drug discovery.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Letter Biochemistry & Molecular Biology

Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19

Nisha Muralidharan et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biochemistry & Molecular Biology

Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes

Ammar D. Elmezayen et al.

Summary: This study attempted to identify commercially available drugs for repurposing against coronavirus through structure-based virtual screening, successfully finding multiple potential inhibitors. The 3D structure of TMPRSS2 was generated using homology modeling, and promising inhibitors were identified through docking studies. ADMET profiles showed that the compounds discovered in the study are safe and drug-like.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biochemistry & Molecular Biology

In-silicoapproaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel

Manoj Kumar Gupta et al.

Summary: This study investigated the structure, function, and interaction of the human SARS-CoV2 E protein with phytochemicals using computational methods. The results showed that certain phytochemicals can inhibit the protein's function, potentially serving as drugs to control diseases caused by SARS-CoV2.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biochemistry & Molecular Biology

Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study

Maryam Enayatkhani et al.

Summary: This study utilized bioinformatics approaches to design a novel multi-epitope vaccine against the novel Coronavirus, potentially triggering multiple immune responses. Computational tools were used to validate the biological activities of the vaccine, predict the binding of the protein candidate with Toll-like receptor 4 and HLA-A*11:01, and molecular dynamics simulation was employed to evaluate the stability of the designed fusion protein with the receptors.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biochemistry & Molecular Biology

Novel guanosine derivatives against MERS CoV polymerase: An in silico perspective

Abdo A. Elfiky et al.

Summary: MERS CoV is a new viral infection with high mortality rate and shares similarity with Hepatitis C Virus RNA dependent RNA polymerase. The study suggests using anti-polymerases as potential candidates against MERS CoV RdRp, and identifies four novel compounds as high performance inhibitors.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Infectious Diseases

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

Philippe Colson et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Letter Infectious Diseases

An interactive web-based dashboard to track COVID-19 in real time

Ensheng Dong et al.

LANCET INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

News Item Medicine, General & Internal

Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

Editorial Material Cardiac & Cardiovascular Systems

COVID-19 and Renin Angiotensin Blockers Current Evidence and Recommendations

Franz H. Messerli et al.

CIRCULATION (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 and COVID-19: The most important research questions

Kit-San Yuen et al.

CELL AND BIOSCIENCE (2020)

Article Pharmacology & Pharmacy

Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes

Min-Han Lin et al.

ANTIVIRAL RESEARCH (2018)

Article Medicine, General & Internal

Sublingual Versus Oral Captopril for Decreasing Blood Pressure in Hypertension Urgency: A Randomized Clinical Trial

Mehdi Mousavi et al.

IRANIAN RED CRESCENT MEDICAL JOURNAL (2018)

Article Chemistry, Multidisciplinary

Using an Old Drug to Target a New Drug Site: Application of Disulfiram to Target the Zn-Site in HCV NS5A Protein

Yu -Ming Lee et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)

Article Biochemistry & Molecular Biology

Inhibition of Urease by Disulfiram, an FDA-Approved Thiol Reagent Used in Humans

Angel Gabriel Diaz-Sanchez et al.

MOLECULES (2016)

Article Microbiology

Disulfiram and Copper Ions Kill Mycobacterium tuberculosis in a Synergistic Manner

Alex G. Dalecki et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)

Article Chemistry, Medicinal

Reduction of Urease Activity by Interaction with the Flap Covering the Active Site

Lee Macomber et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)

Article Substance Abuse

Efficacy of Disulfiram for the Treatment of Alcohol Dependence Assessed with a Multicenter Randomized Controlled Trial

Atsushi Yoshimura et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2014)

Article Biochemistry & Molecular Biology

Structural Basis for Inactivation of Giardia lamblia Carbamate Kinase by Disulfiram

Andrey Galkin et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Chemistry, Medicinal

LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery

Roman A. Laskowski et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)

Article Biochemistry & Molecular Biology

Disulfiram irreversibly aggregates betaine aldehyde dehydrogenase -: A potential target for antimicrobial agents against Pseudomonas aeruginosa

R Velasco-García et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Biochemistry & Molecular Biology

Inactivation of betaine aldehyde dehydrogenase from Pseudomonas aeruginosa and Amaranthus hypochondriacus L. leaves by disulfiram

R Velasco-García et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2003)

Article Biotechnology & Applied Microbiology

Conservation of substrate specificities among coronavirus main proteases

A Hegyi et al.

JOURNAL OF GENERAL VIROLOGY (2002)

Article Biochemistry & Molecular Biology

In vivo inhibition of aldehyde dehydrogenase by disulfiram

JJ Lipsky et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2001)